Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue
+14.1%
Free cash flow
+916.1%
Total debt
−23.7%

Quarter to September 2026, against a year earlier

39.62 0.14 −0.35%
Market cap
$52.3B
P/E
58.4×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.25
Beneish M
−2.38
Dividend safety
n/a

Medline Inc. (MDLN) Free cash flow

Alert me on Free cash flow

Medline Inc.'s free cash flow for fiscal 2025 was $1.3B, down 8.34% from $1.4B in fiscal 2024. Over the twelve months to 30 September 2026 it was $3.1B. Medline Inc. ranks 3rd of 51 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $1.3B (8.34%)
FY2024 $1.4B 0.35%
FY2023 $1.4B —

Quarterly newest first

Period Free cash flow Change
Sep 2026 $884.0M 46.36%
Jun 2026 $604.0M 91.14%
Mar 2026 $316.0M (75.64%)
Dec 2025 $1.3B 1,390.80%
4 more quarters

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on MDLN